miR-29a down-regulates DNMT3A and −3B in lung cancer cells47 and hepatocytes48 while targets TET in malignant hematopoietic cells49, hepatocellular carcinoma cells50, breast cancer cells and embryonic stem cells51,52. Here, DNMT3A is linked to breast carcinoma.